Skip to main content

Company and membership meetings



Rules and recommendations

Due to the pandemic, it is difficult to hold general meetings of companies or membership meetings. However, the government passed a law that responds to the effects of the epidemic.

If it is not possible to meet in person to discuss a certain important issue the law defines the rules for taking decisions while emergency measures are in effect. This applies even if it is not enshrined in the articles of an association.

Specifically, it is possible to use technical tools such as teleconferencing or decision-making per rollam (i.e. by mail or e-mail).

The option applies in general to legal entities, i.e. Private Limited Company, corp, and societies

The validity of the above-mentioned rules was extended by Act No. 460/2020 Coll. until June 30, 2021.

Special regime measures have been taken in case of a meeting held in person with more than 10 participants, they are:

  • each person must wear a FFP2, KN95 or N 95 class respirator,
  • persons are seated so as to maintain a 1-seat gap between each other's seats (this does not apply to a group of persons sharing one household).

Furthermore, at least one of the following conditions must have been met by each person present (this has to be proven upon entering the venue):

  • having undergone an PCR testing with a negative test result, provided the testing took place not longer than 7 days prior to the meeting,
  • having undergone an POC antigene testing with a negative test result, provided the testing took place not longer than 72 hours prior to the meeting,
  • having undergone a testing at school or the person's workplace with a negative test result, provided the testing took place not longer than 72 hours prior to the meeting,
  • having survived a COVID-19 infection not longer than 180 days prior to the meeting,
  • having got vaccinated, provided either the first dose has been administered at least 22 days prior to the meeting, the timespan between the doses does not exceed 90 days and the one since the second dose has been administered 9 months (two-dose vaccination scheme) or the dose has been administered at least 14 days, however not longer than 9 months prior to the meeting (single-dose vaccination scheme).

Related links and sources